📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 325 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
325
இன்று
169,026
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,991
நேர்மறை
8,543
எதிர்மறை
100,681
நடுநிலை
9,743
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
181 அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: APOLLO
நேர்மறை தாக்கம் 7/10 வழக்கமானது

Apollo Hospitals Assigned ICRA AAA (Stable) Credit Rating for Rs 3,000 Crore Bank Facilities

Apollo Hospitals Enterprise Limited has received new credit ratings from ICRA Limited for its bank facilities totaling Rs 3,000 crore. The rating agency assigned an '[ICRA]AAA (Stable)' rating for long-term fund-based term loans amounting to Rs 2,052 crore. Additionally, unallocated long-term/short-term limits of Rs 948 crore were assigned '[ICRA]AAA (Stable) / [ICRA]A1+' ratings. This highest-tier credit rating reflects the company's exceptionally strong financial profile and robust debt-servicing capability.

நேர்மறை தாக்கம் 8/10 விரிவாக்கம்

Apollo Micro Systems Transitions to OEM; IDL Explosives Debt-Free with 5x Cash Growth

Apollo Micro Systems (AMS) is undergoing a strategic shift from a Tier-1 electronics supplier to a full-scale Original Equipment Manufacturer (OEM) for defense platforms. The company successfully integrated IDL Explosives, which is now debt-free and has seen its cash position grow 5x year-on-year. AMS has secured critical DPIIT licenses for manufacturing UAVs, missiles, and torpedoes, positioning itself to capture a share of India's targeted ‡3 lakh crore domestic defense production by 2029. The company also reported receiving its first export order, marking its entry into the global defense market.

நேர்மறை தாக்கம் 9/10 நிதி முடிவுகள்

Apollo Micro Systems Reports Record FY26 PAT of ₹107.4 Cr, Up 90.5% YoY; Order Book at ₹1432 Cr

Apollo Micro Systems delivered a breakthrough performance in FY26, with annual revenue surging 61% to ₹904.32 Cr and PAT growing 90.5% to ₹107.38 Cr. The company achieved its highest-ever quarterly revenue of ₹293.26 Cr in Q4FY26, marking an 81.3% YoY growth. Profitability margins improved significantly, with the annual PAT margin rising from 10% to 12%. The growth is backed by a robust consolidated order book of ₹1432 Cr and strategic milestones including UAV manufacturing licenses and the company's first export order.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Tyres Q4 FY26: Revenue Up 14%, Net Debt/EBITDA at 0.4x, ₹35B CapEx Planned for FY27

Apollo Tyres reported a strong Q4 FY26 with consolidated revenue growing 14% YoY to INR 73.4 billion and EBITDA margins expanding to 14.6%. The company significantly strengthened its balance sheet, reducing Net Debt/EBITDA to 0.4x from 3.2x in 2020. Management has outlined a substantial CapEx of INR 35 billion for FY27, primarily focused on capacity expansion in India. However, near-term margins face pressure from rising raw material costs expected to increase in high teens, which the company is mitigating through price hikes of 6-8%.

நேர்மறை தாக்கம் 7/10 BOARD_MEETING

Apollo Micro Systems Recommends Re 0.25 Dividend and Announces Management Changes

Apollo Micro Systems has approved its audited financial results for the fiscal year ending March 31, 2026, with the statutory auditor issuing an unmodified opinion. The Board recommended a final dividend of Re 0.25 (0.25 paisa) per equity share of face value Rs. 1 for shareholder approval. Significant management updates include the resignation of Ms. Rukhya Parveen as Company Secretary and the appointment of Mr. G. Seshadri Vasan as the new Compliance Officer effective June 1, 2026. The company also re-appointed its cost and internal auditors for the 2026-2027 financial year to ensure continued regulatory compliance.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நேர்மறை தாக்கம் 7/10 BOARD_MEETING

Apollo Micro Systems Recommends ₹0.25 Dividend and Approves FY26 Audited Results

Apollo Micro Systems has approved its audited financial results for the fiscal year ended March 31, 2026, with a clean (unmodified) audit opinion. The Board recommended a final dividend of ₹0.25 per equity share (25% of face value) for shareholder approval. Significant management changes were announced, including the appointment of Mr. G. Seshadri Vasan as Company Secretary effective June 1, 2026. Additionally, the company has re-appointed its cost and internal auditors for the 2026-2027 financial year to ensure continuity in compliance.

நடுநிலை தாக்கம் 6/10 ஒழுங்குமுறை

Apollo Micro Systems Reports Zero Deviation in Utilization of Rs 185.13 Cr Preferential Issue Funds

Apollo Micro Systems has confirmed that there was no deviation or variation in the utilization of funds raised through its preferential issue for the quarter ended March 31, 2026. The company successfully utilized Rs 185.13 Crores, which represented the 75% warrant application money received in the preceding quarter. While the total issue size was revised downward to Rs 742.25 Crores from Rs 816.08 Crores due to a shortfall in receipts, the allocation remains proportional to the original objects. The funds are being deployed across working capital, R&D for futuristic technologies, and general corporate purposes.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Tyres Q4 FY26 Revenue Up 14.2% YoY; EBITDA Margins Expand to 14.6%

Apollo Tyres reported a strong Q4 FY26 with consolidated revenue growing 14.2% YoY to INR 73,357 Mn, driven by robust demand in the Indian replacement and OE markets. EBITDA margins expanded significantly by 153 bps to 14.6%, resulting in a 27.6% YoY growth in EBITDA to INR 10,688 Mn. The company successfully reduced its net debt to INR 16 Bn, bringing the Net Debt/EBITDA ratio down to a healthy 0.4x. While the European segment saw a slight revenue dip in Euro terms, the premium product mix (UHP) improved to 50%, supporting overall profitability.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Tyres FY26 PAT Jumps to ₹18,518 Mn; Total Dividend Declared at ₹6.00 Per Share

Apollo Tyres reported a robust FY26 with standalone revenue rising to ₹198,162 million from ₹181,736 million in FY25. Net profit for the full year saw a massive increase to ₹18,518 million, significantly supported by a deferred tax credit of ₹5,041 million in the final quarter. The company has rewarded shareholders with a total dividend of ₹6.00 per share for the fiscal year, representing a 600% payout on face value. Additionally, the board approved the re-appointment of Ms. Lakshmi Puri as an Independent Director for a second five-year term.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Pipes Targets INR 5,000 Cr Revenue by FY31; Guides for INR 400 Cr+ in Q1 FY27

Apollo Pipes has announced an ambitious 5-year growth plan to achieve a 35% revenue CAGR, aiming for INR 5,000 crores by FY31. Despite a 30% decline in consolidated EBITDA in FY26 due to PVC price volatility and inventory write-downs, the company crossed 1 lakh tons in annual sales volume. Management is guiding for a strong Q1 FY27 with revenue expected to exceed INR 400 crores, driven by aggressive pricing and group synergies. The company is expanding its capacity with a new plant in South India and focusing on allied products like bath fittings and windows.

நடுநிலை தாக்கம் 7/10 M&A

Apollo Hospitals Receives NCLT Order to Reschedule Stakeholder Meetings for Composite Scheme

Apollo Hospitals Enterprise Limited has received a certified order from the NCLT Chennai Bench regarding its Composite Scheme of Arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech. The Tribunal has approved the company's request to reschedule meetings for equity shareholders and creditors to late June 2026. This procedural update is part of the ongoing restructuring to consolidate the company's pharmacy and digital health businesses. The equity shareholders' meeting is now officially set for June 24, 2026.

நேர்மறை தாக்கம் 7/10 மற்றவை

Apollo Micro Systems Bags New Orders Worth ₹510.25 Million Across Defence and Private Sectors

Apollo Micro Systems Limited has secured new business orders totaling ₹510.25 million in its ordinary course of business. The orders are diversified across the Ministry of Defence (₹174.78 million), Public Sector Defence Undertakings (₹95.28 million), and various private companies (₹240.18 million). This influx of orders strengthens the company's order book and reinforces its position within the Indian defence electronics ecosystem. The significant contribution from private companies indicates a broadening client base beyond government entities.

எதிர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Pipes Recommends ₹0.70 Dividend; FY26 Net Profit Drops 86% to ₹4.66 Crore

Apollo Pipes reported a significant decline in financial performance for FY26, with consolidated net profit falling 86.3% to ₹4.66 crore from ₹34.09 crore in the previous year. Revenue from operations also decreased slightly to ₹1,104.92 crore. Despite the profit slump, the board recommended a final dividend of ₹0.70 per share. The company also announced a leadership transition with Mr. Sanjay Gupta appointed as Chairman and the introduction of a new Stock Appreciation Rights (SAR) scheme for employees.

கண்காணிப்பு தாக்கம் 8/10 நிதி முடிவுகள்

Apollo Pipes Q4FY26 Revenue Up 10% to ₹347 Cr; FY26 PAT Drops 77% Amid Margin Pressure

Apollo Pipes reported a recovery in Q4FY26 with revenue growing 10% YoY to ₹347 Cr and sales volumes increasing 21% to 31,366 MT. However, the full-year FY26 performance was weak, with PAT declining 77% to ₹7.5 Cr and EBITDA falling 31% to ₹66.5 Cr. The company has transitioned from a net cash position of ₹46 Cr to a net debt of ₹40 Cr following the acquisition of Kisan Mouldings. Despite bottom-line pressure, management is targeting 25%+ revenue growth in FY27, supported by a total capacity of 2,40,000 MTPA and new product launches.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

APL Apollo Reports Strong FY26 Results with 37% ROCE and INR 5,500+ EBITDA/Ton in Q4

APL Apollo Tubes delivered a robust performance for Q4 FY26, achieving a 9% YoY volume growth and EBITDA per ton exceeding INR 5,500. Despite headwinds from the Middle East crisis impacting Dubai operations and domestic raw material shortages, the company maintained a 37% ROCE and generated INR 13 billion in free cash flow for the full year. Management is prioritizing profitability over volume in the short term while remaining on track for an 8-million-ton capacity target by FY28. With a net cash balance of over INR 15 billion, the company is considering higher dividends or buybacks as it eliminates remaining debt.

நேர்மறை தாக்கம் 9/10 நிதி முடிவுகள்

APL Apollo FY26 Net Profit Surges 59% to ₹12.0 Bn; EBITDA/Ton Hits Record ₹5,161

APL Apollo Tubes delivered a robust performance for FY26, with consolidated net profit growing 59% YoY to ₹12.0 billion. The company achieved its highest-ever quarterly volume of 925k tons in Q4FY26, contributing to an annual volume growth of 11% to 3,491k tons. Operational efficiency improved significantly, with EBITDA per ton rising 36% to ₹5,161 and ROCE expanding to 37.3%. The company maintains a strong balance sheet with a net cash position of ₹15.3 billion and zero net working capital days.

நேர்மறை தாக்கம் 9/10 நிதி முடிவுகள்

APL Apollo Q4FY26 PAT Rises 21% to ₹3.5Bn; FY26 Net Profit Surges 59% YoY

APL Apollo Tubes reported a robust performance for Q4FY26, with net profit increasing 21% YoY to ₹3.5 billion and revenue growing 14% to ₹62.7 billion. For the full year FY26, the company achieved a massive 59% growth in PAT to ₹12.0 billion, supported by an 11% volume growth and a 36% jump in EBITDA per ton to ₹5,161. The company maintains a strong balance sheet with a net cash position of ₹15.3 billion and zero net working capital days. Management has outlined a clear growth path to reach 8 million tons of capacity by FY28, up from the current 5 million tons.

நேர்மறை தாக்கம் 8/10 BOARD_MEETING

APL Apollo Recommends ₹8.50 Dividend and Plans Non-Core Asset Divestment

APL Apollo Tubes has recommended a final dividend of ₹8.50 per share (425%) for FY26 following its board meeting. The company is streamlining its corporate structure by initiating the voluntary liquidation of APL Apollo Mart Limited, which contributed a negligible 0.04% to consolidated revenue. Furthermore, the board granted in-principle approval to divest its real estate subsidiary, Blue Ocean Projects, to redeploy capital into its core manufacturing operations. Four independent directors have also been re-appointed for second five-year terms, ensuring leadership continuity.

நேர்மறை தாக்கம் 8/10 டிவிடெண்ட்

APL Apollo Recommends ₹8.50 Final Dividend and Announces Corporate Restructuring

APL Apollo Tubes has recommended a final dividend of ₹8.50 per equity share (425% of face value) for FY26. The company is also streamlining its operations by initiating the voluntary liquidation of its non-operational subsidiary, APL Apollo Mart Limited, and divesting its real estate holding subsidiary, Blue Ocean Projects. These moves are part of a capital allocation strategy to unlock funds and redeploy them into the core manufacturing business. Additionally, the board has re-appointed four independent directors for second five-year terms, ensuring management continuity.

நேர்மறை தாக்கம் 8/10 M&A

Apollo Hospitals Receives NCLT Order for Keimed-Healthco Merger; Meetings Set for May 27, 2026

Apollo Hospitals has received the NCLT order regarding its composite scheme of arrangement involving Apollo Healthco, Keimed Private Limited, and Apollo Healthtech. The tribunal has scheduled meetings for equity shareholders and unsecured creditors of the company on May 27, 2026, to vote on the restructuring proposal. This scheme aims to integrate the pharmacy distribution business of Keimed with Apollo's digital health and pharmacy platform. A high consent level of 90.96% from certain secured creditors has already been noted by the tribunal.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்